Head-to-head · WeighScore
9amHealth vs NexLife
The verdict
9amHealth takes it — 71.3/100 to 68.5/100.
9amHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | 9amHealth | NexLife |
|---|---|---|
| WeighScore | 71.3/100 | 68.5/100 |
| Grade | C | C |
| Scorecard rank | #94 | #147 |
| Semaglutide | $149/mo (plus a separate fee, brand-name) | $165/mo (compounded) |
| Tirzepatide | Not disclosed | $215/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #94 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- $149/month membership or free when covered by insurance
- Membership includes specialists, labs, devices, and medications
- Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- Helps navigate insurance approvals; employer and state-plan partnerships
Where it loses points
- Medication coverage and GLP-1 access depend on insurance and BMI criteria
- State availability not enumerated on the public site
- Branded GLP-1s can be costly without insurance coverage
- Pricing for medications not transparently listed
Graded #147 · C
Strengths
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
Where it loses points
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.